Profile data is unavailable for this security.
About the company
Convatec Group Plc is a United Kingdom-based medical products and technologies company. The Company is engaged in the development, manufacture and sale of medical products, services, and technologies. It is focused on solutions for the management of chronic conditions. It markets and sells its solutions and services in four categories, such as Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Its Advanced Wound Care includes advanced solutions for the management of acute and chronic wounds resulting from ongoing conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. Ostomy Care includes devices, accessories and personalized services for individuals with a stoma. Its Continence and Critical Care includes products and services for people with urinary continence issues, and other devices for critical care. Its Infusion Care includes disposable infusion sets used in insulin pump therapy for people with diabetes.
- Revenue in GBP (TTM)1.72bn
- Net income in GBP104.33m
- Incorporated2016
- Employees10.13k
- LocationConvaTec Group PLC7th Floor, 20 Eastbourne TerraceLONDON W2 6LGUnited KingdomGBR
- Websitehttps://www.convatecgroup.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Embla Medical hf | 643.82m | 45.57m |
SKAN Group AG | 280.22m | 23.04m |
Medacta Group SA | 437.12m | 40.53m |
Elekta AB (publ) | 1.34bn | 105.03m |
Ambu A/S | 562.17m | 27.32m |
GN Store Nord A/S | 2.08bn | 26.17m |
Ypsomed Holding AG | 445.35m | 63.41m |
Getinge AB | 2.36bn | 167.40m |
SCHOTT Pharma AG & Co KgaA | 775.36m | 135.37m |
ConvaTec Group PLC | 1.72bn | 104.33m |
Amplifon SpA | 1.93bn | 132.82m |
Carl Zeiss Meditec AG | 1.79bn | 236.94m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Black Creek Investment Management, Inc.as of 23 Apr 2024 | 102.41m | 5.00% |
Artisan Partners LPas of 31 Dec 2022 | 97.98m | 4.78% |
Capital Research & Management Co. (Global Investors)as of 31 Dec 2022 | 97.42m | 4.75% |
Schroder Investment Management Ltd.as of 02 Apr 2024 | 57.57m | 2.81% |
The Vanguard Group, Inc.as of 02 Apr 2024 | 56.05m | 2.73% |
Massachusetts Financial Services Co.as of 02 Apr 2024 | 48.62m | 2.37% |
Royal London Asset Management Ltd.as of 02 Apr 2024 | 45.30m | 2.21% |
abrdn Investment Management Ltd.as of 31 Dec 2022 | 43.37m | 2.12% |
FIL Investment Advisors (UK) Ltd.as of 02 Apr 2024 | 40.58m | 1.98% |
BlackRock Investment Management (UK) Ltd.as of 15 May 2023 | 39.63m | 1.93% |